Sanofi Consumer Healthcare India Cash Flow
- Market cap
- ₹8,181 crore
- P/E
- 22.5
- P/B
- 2.85
- ROE
- 14.5%
- Dividend yield
- 1.20%
- 52-week range
- ₹2,557.58 – ₹4,795.47
In the year ended FY25, Sanofi Consumer Healthcare India generated ₹491 crore from operating activities, invested ₹327 crore and paid out ₹123 crore on financing activities. Net cash flow for the year was ₹40.9 crore. Free cash flow was ₹205 crore.
Sanofi Consumer Healthcare India cash flow statement
Financial years, newest first. Negative figures are cash outflows.
| Item | FY25 |
|---|---|
| Cash from operating activities | 491 |
| Cash from investing activities | -327 |
| Cash from financing activities | -123 |
| Net cash flow | 40.9 |
| Capital expenditure | 286 |
| Free cash flow | 205 |
Source: Company filings, in ₹ crore. Data as of 9 October 2026. How this data is compiled.
Sanofi Consumer Healthcare India cash flow — frequently asked questions
What is Sanofi Consumer Healthcare India's operating cash flow?
Sanofi Consumer Healthcare India's cash flow from operating activities was ₹491 crore in the year ended FY25.
What is Sanofi Consumer Healthcare India's free cash flow?
Sanofi Consumer Healthcare India's free cash flow — operating cash flow minus capital expenditure — was ₹205 crore in FY25, after capital expenditure of ₹286 crore.
How much did Sanofi Consumer Healthcare India spend on investing activities?
Net cash used in investing activities was ₹327 crore in FY25. This covers capital expenditure, acquisitions and the purchase or sale of investments.
Same Data For Peers
Trade Sanofi Consumer Healthcare India With ATS
Track SANOFICONR live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.